vTv Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 4.5 million compared to USD 7.01 million a year ago. Basic loss per share from continuing operations was USD 2.4 compared to USD 4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.99 USD | -3.13% | +9.99% | +126.00% |
May. 09 | VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+126.00% | 63.23M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.12% | 22.25B | |
-13.14% | 22.09B | |
-8.17% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023